drugset / Trial / NCT02940184

GLP-1 Signaling in Truncally Vagotomized Subjects

NCT02940184

RandomizedCrossoverOpen-labelBasic science

Summary

Investigation of the importance of vagal signaling for the glucohomeostatic effects of GLP-1. The study will include physiological studies of truncally vagotomized participants and matched controls.

Timeline

Start
2016-06
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg

Indications

No indication recorded.